amlodipine / olmesartan
- RxCUI
- 1009015
- RxNorm name
- amlodipine / olmesartan
- Term type
- MIN
- Status
- Active
- Updated
- 2026-10-24 12:25:42
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092010
- Active start
- 092010
- Multiple ingredient
- YES
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| amlodipine | 17767 |
| olmesartan | 321064 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | amLODIPine / olmesartan | 1 | NAMES |
| RxNorm Name | amlodipine / olmesartan | 1 | NAMES |
| TTY | MIN | 1 | ATTRIBUTES |
| RxCUI | 1009015 | 1 | CODES |
| MMSL_CODE | GNd06905 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C09CA | Angiotensin II receptor blockers (ARBs), plain | ATC1-4 | olmesartan medoxomil | |
| ATC | C08CA | Dihydropyridine derivatives | ATC1-4 | amlodipine | |
| FDASPL | D004095 | Dihydropyridines | CHEM | has_chemical_structure | amlodipine |
| FDASPL | N0000175561 | Angiotensin 2 Receptor Blocker | EPC | has_epc | olmesartan |
| FDASPL | N0000175566 | Calcium Channel Blocker | EPC | has_epc | amlodipine |
| FDASPL | N0000175421 | Dihydropyridine Calcium Channel Blocker | EPC | has_epc | amlodipine |
| FDASPL | N0000000070 | Angiotensin 2 Receptor Antagonists | MOA | has_moa | olmesartan |
| FDASPL | N0000000069 | Calcium Channel Antagonists | MOA | has_moa | amlodipine |
| FDASPL | N0000190114 | Cytochrome P450 3A Inhibitors | MOA | has_moa | amlodipine |
| MEDRT | D017311 | Amlodipine | CHEM | has_ingredient | amlodipine |
| MEDRT | D007093 | Imidazoles | CHEM | has_ingredient | olmesartan |
| MEDRT | D000068557 | Olmesartan Medoxomil | CHEM | has_ingredient | olmesartan medoxomil |
| MEDRT | D013777 | Tetrazoles | CHEM | has_ingredient | olmesartan |
| MEDRT | D000788 | Angina Pectoris, Variant | DISEASE | may_treat | amlodipine |
| MEDRT | D003324 | Coronary Artery Disease | DISEASE | may_treat | amlodipine |
| MEDRT | D003928 | Diabetic Nephropathies | DISEASE | may_treat | olmesartan |
| MEDRT | D003928 | Diabetic Nephropathies | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | olmesartan |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | amlodipine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D006333 | Heart Failure | DISEASE | may_treat | olmesartan |
| MEDRT | D006333 | Heart Failure | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | D006929 | Hyperaldosteronism | DISEASE | ci_with | olmesartan |
| MEDRT | D006929 | Hyperaldosteronism | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | olmesartan |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | amlodipine |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | amlodipine |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | olmesartan |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | olmesartan |
| MEDRT | D018487 | Ventricular Dysfunction, Left | DISEASE | may_treat | olmesartan |
| MEDRT | D018487 | Ventricular Dysfunction, Left | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | N0000000070 | Angiotensin 2 Receptor Antagonists | MOA | has_moa | olmesartan medoxomil |
| MEDRT | N0000000070 | Angiotensin 2 Receptor Antagonists | MOA | has_moa | olmesartan |
| MEDRT | N0000020065 | L-Calcium Channel Receptor Antagonists | MOA | has_moa | amlodipine |
| MEDRT | N0000008375 | Coronary Arterial Vasodilation | PE | has_pe | amlodipine |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | amlodipine |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | ci_pe | amlodipine |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | olmesartan |
| MEDRT | N0000008669 | Decreased Intravascular Volume | PE | has_pe | olmesartan |
| MEDRT | N0000008669 | Decreased Intravascular Volume | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000008731 | Decreased Mineralocorticoid Secretion | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000008731 | Decreased Mineralocorticoid Secretion | PE | has_pe | olmesartan |
| MEDRT | N0000008859 | Decreased Renal K+ Excretion | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000008859 | Decreased Renal K+ Excretion | PE | has_pe | olmesartan |
| MEDRT | N0000009553 | Increased Renal Na+ Excretion | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000009553 | Increased Renal Na+ Excretion | PE | has_pe | olmesartan |
| MEDRT | N0000009825 | Renal Arterial Vasoconstriction | PE | ci_pe | olmesartan medoxomil |
| MEDRT | N0000009825 | Renal Arterial Vasoconstriction | PE | ci_pe | olmesartan |
| MEDRT | N0000009826 | Renal Arterial Vasodilation | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000009826 | Renal Arterial Vasodilation | PE | has_pe | olmesartan |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| CODES | SNOMEDCT | 428304009 |
| CODES | VUID | 4026969 |
| NAMES | Tallman Synonym | amLODIPine / olmesartan |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |